Evidence map›Paper›PMID 39229818›Full record

SynthesisPharmacogenomics2024

Accuracy and technical characteristics of CYP2C19 point of care tests: a systematic review.

Eve Tomlinson, Chris Cooper, Hayley E Jones, Catalina Lopez Manzano, Rachel Palmer, Joe Carroll, Ayman Sadek, Nicky J Welton, Mariska Leeflang, Penny Whiting

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Pharmacogenomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eve TomlinsonPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.ORCID 0000-0002-0969-602X
Chris CooperPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.ORCID 0000-0003-0864-5607
Hayley E JonesPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.ORCID 0000-0002-4265-2854
Catalina Lopez ManzanoPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.ORCID 0009-0009-8883-0167
Rachel PalmerSouth West NHS Genomic Medicine Service Alliance.ORCID 0009-0006-6253-3330
Joe CarrollPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.ORCID 0009-0004-7006-0938
Ayman SadekPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.ORCID 0009-0000-6565-0790
Nicky J WeltonPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.ORCID 0000-0003-2198-3205
Mariska LeeflangAmsterdam University Medical Centers, University of Amsterdam.ORCID 0000-0001-5960-0471
Penny WhitingPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.ORCID 0000-0003-1138-5682

Funding

National Institute for Health Research NIHR135620
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cytochrome P-450 CYP2C19AllelesHumansPlatelet Aggregation InhibitorsPoint-of-Care SystemsPoint-of-Care TestingCYP2C19 protein, humanCytochrome P-450 CYP2C19Platelet Aggregation Inhibitorsantiplatelet therapyclopidogrelCYP2C19 testingdiagnostic test accuracymeta-analysissystematic review

Identifiers

PMID39229818
PMCPMC11418221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.